Tapewire

NYSE · USD

SMHI

SEACOR Marine Holdings Inc.

Export transactions ↓
Tapewire entity
6091
SEC CIK
0001690334
Parsed reports
282

Last 12 months

Inside the activity.

0 purchase rows · 32 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202608
Jul 2026011
Aug 2026010
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 11, 2019 Filed Jun 12, 2019 23:44 UTC GrantCommon Stock 5,813 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-036548 · doc4.xml · nonDerivative · entry 1

MORSE ANDREW R · CIK 0001254946 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,815

Read SEC document
June 11, 2019 Filed Jun 13, 2019 00:30 UTC Amendment GrantStock Options (right to buy) · Derivative 7,929 $0.00 Strike: $13.83 $0.00
Disclosure

SEC source: 0001209191-19-036568 · doc4a.xml · derivative · entry 5

Regan Robert Christopher · CIK 0001338856 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,929

Underlying: Common Stock · 7,929 shares

Expires 2029-06-11

Read SEC document
June 11, 2019 Filed Jun 13, 2019 00:30 UTC Amendment GrantCommon Stock 6,175 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-036568 · doc4a.xml · nonDerivative · entry 1

Regan Robert Christopher · CIK 0001338856 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,778

Read SEC document
June 11, 2019 Filed Jun 12, 2019 23:51 UTC GrantStock Options (right to buy) · Derivative 7,929 $0.00 Strike: $13.83 $0.00
Disclosure

SEC source: 0001209191-19-036552 · doc4.xml · derivative · entry 5

Regan Robert Christopher · CIK 0001338856 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,929

Underlying: Common Stock · 7,929 shares

Expires 2029-06-11

Read SEC document
June 11, 2019 Filed Jun 12, 2019 23:51 UTC GrantCommon Stock 6,175 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-036552 · doc4.xml · nonDerivative · entry 1

Regan Robert Christopher · CIK 0001338856 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,778

Read SEC document
June 11, 2019 Filed Jun 12, 2019 23:48 UTC GrantStock Options (right to buy) · Derivative 7,929 $0.00 Strike: $13.83 $0.00
Disclosure

SEC source: 0001209191-19-036550 · doc4.xml · derivative · entry 2

Persily Julie · CIK 0001593007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,929

Underlying: Common Stock · 7,929 shares

Expires 2029-06-11

Read SEC document
June 11, 2019 Filed Jun 12, 2019 23:48 UTC GrantCommon Stock 4,366 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-036550 · doc4.xml · nonDerivative · entry 1

Persily Julie · CIK 0001593007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,154

Read SEC document
June 11, 2019 Filed Jun 12, 2019 23:41 UTC GrantStock Options (right to buy) · Derivative 7,929 $0.00 Strike: $13.83 $0.00
Disclosure

SEC source: 0001209191-19-036546 · doc4.xml · derivative · entry 3

Miguel Bejos Alfredo · CIK 0001777507 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,929

Underlying: Common Stock · 7,929 shares

Expires 2029-06-11

Read SEC document
June 11, 2019 Filed Jun 12, 2019 23:41 UTC GrantCommon Stock 3,280 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-036546 · doc4.xml · nonDerivative · entry 1

Miguel Bejos Alfredo · CIK 0001777507 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,280

Read SEC document
June 11, 2019 Filed Aug 31, 2020 20:53 UTC Amendment SaleCommon Stock 5,724 $13.92 $79,678.08
Disclosure

SEC source: 0001209191-20-048793 · doc4a.xml · nonDerivative · entry 1

Miguel Bejos Alfredo · CIK 0001777507 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Proyectos Globales de Energia y Servicios CME, S.A. de C.V.

Disclosed balance after: 980,437

F1 · shares: The Reporting Person's original Form 4 omitted the sale of 5,724 shares on 6/11/19 by Projectos Globales de Energia y Servicios CME, S.A. de C.V. ("CME"). The correction of this omission results in indirect beneficial ownership of 980,437 shares as of 6/11/19. This omission was also reflected in the reported indirect beneficial ownership of shares set forth in each Form 4 filed by the Reporting Person after the original Form 4 was filed. As of 8/31/20, the Reporting Person has indirect beneficial ownership of 744,693 shares through CME.

F2 · ownership.nature: The Reporting Person is the President, Chief Executive Officer and a shareholder of CME. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest in the securities.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:01 UTC GrantPerformance Restricted Stock Units · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025261 · doc4.xml · derivative · entry 3

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:01 UTC GrantStock Options (right to buy) · Derivative 3,750 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001209191-19-025261 · doc4.xml · derivative · entry 2

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2029-04-16

F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:01 UTC GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025261 · doc4.xml · nonDerivative · entry 1

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,629

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:02 UTC
Weller AnthonySVP/Managing Dir-Int'l Div
GrantPerformance Restricted Stock Units · Derivative 6,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025262 · doc4.xml · derivative · entry 3

Weller Anthony · CIK 0001705744 · SVP/Managing Dir-Int'l Div

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,800

Underlying: Common Stock · 6,800 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:02 UTC
Weller AnthonySVP/Managing Dir-Int'l Div
GrantStock Options (right to buy) · Derivative 1,875 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001209191-19-025262 · doc4.xml · derivative · entry 2

Weller Anthony · CIK 0001705744 · SVP/Managing Dir-Int'l Div

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2029-04-16

F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:02 UTC
Weller AnthonySVP/Managing Dir-Int'l Div
GrantCommon Stock 10,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025262 · doc4.xml · nonDerivative · entry 1

Weller Anthony · CIK 0001705744 · SVP/Managing Dir-Int'l Div

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,110

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:00 UTC
Llorca JesusEVP & CFO
GrantPerformance Restricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025260 · doc4.xml · derivative · entry 3

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:00 UTC
Llorca JesusEVP & CFO
GrantStock Options (right to buy) · Derivative 6,250 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001209191-19-025260 · doc4.xml · derivative · entry 2

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2029-04-16

F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 21:00 UTC
Llorca JesusEVP & CFO
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025260 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,249

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:59 UTC
Gellert John MDirector · President and CEO
GrantPerformance Restricted Stock Units · Derivative 28,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025258 · doc4.xml · derivative · entry 7

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,000

Underlying: Common Stock · 28,000 shares

Expires not disclosed

F7 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F8 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

F8 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:59 UTC
Gellert John MDirector · President and CEO
GrantStock Options (right to buy) · Derivative 8,750 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001209191-19-025258 · doc4.xml · derivative · entry 6

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,750

Underlying: Common Stock · 8,750 shares

Expires 2029-04-16

F6 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:59 UTC
Gellert John MDirector · President and CEO
GrantCommon Stock 42,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025258 · doc4.xml · nonDerivative · entry 1

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,085

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:58 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantPerformance Restricted Stock Units · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025257 · doc4.xml · derivative · entry 3

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:58 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantStock Options (right to buy) · Derivative 3,750 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001209191-19-025257 · doc4.xml · derivative · entry 2

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2029-04-16

F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:58 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025257 · doc4.xml · nonDerivative · entry 1

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,813

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:57 UTC GrantPerformance Restricted Stock Units · Derivative 18,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025256 · doc4.xml · derivative · entry 3

Clemons Robert · CIK 0001705909 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,800

Underlying: Common Stock · 18,800 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F4 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

F4 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $15.61, $17.77, $20.06, $22.34 and $24.50, respectively.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:57 UTC GrantStock Options (right to buy) · Derivative 6,250 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0001209191-19-025256 · doc4.xml · derivative · entry 2

Clemons Robert · CIK 0001705909 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2029-04-16

F2 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
April 16, 2019 Filed Apr 18, 2019 20:57 UTC GrantCommon Stock 28,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-025256 · doc4.xml · nonDerivative · entry 1

Clemons Robert · CIK 0001705909 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,896

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2020 and ending on March 4, 2022.

Read SEC document
March 07, 2019 Filed Mar 12, 2019 00:57 UTC Tax withholdingCommon Stock 371 $12.09 $4,485.39
Disclosure

SEC source: 0001209191-19-018654 · doc4.xml · nonDerivative · entry 1

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,629

Read SEC document
March 07, 2019 Filed Mar 12, 2019 00:56 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
Tax withholdingCommon Stock 1,687 $12.09 $20,395.83
Disclosure

SEC source: 0001209191-19-018652 · doc4.xml · nonDerivative · entry 1

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,813

Read SEC document
March 07, 2019 Filed Mar 12, 2019 00:56 UTC
Gellert John MDirector · President and CEO
Tax withholdingCommon Stock 3,419 $12.09 $41,335.71
Disclosure

SEC source: 0001209191-19-018653 · doc4.xml · nonDerivative · entry 1

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,085

Read SEC document
March 07, 2019 Filed Mar 12, 2019 00:55 UTC Tax withholdingCommon Stock 1,802 $12.09 $21,786.18
Disclosure

SEC source: 0001209191-19-018651 · doc4.xml · nonDerivative · entry 1

Clemons Robert · CIK 0001705909 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,696

Read SEC document
March 04, 2019 Filed Mar 6, 2019 00:51 UTC
Gellert John MDirector · President and CEO
Tax withholdingCommon Stock 3,345 $14.01 $46,863.45
Disclosure

SEC source: 0001209191-19-017112 · doc4.xml · nonDerivative · entry 2

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,504

Read SEC document
March 04, 2019 Filed Mar 6, 2019 00:49 UTC Tax withholdingCommon Stock 833 $14.01 $11,670.33
Disclosure

SEC source: 0001209191-19-017109 · doc4.xml · nonDerivative · entry 1

Clemons Robert · CIK 0001705909 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,498

Read SEC document
March 04, 2019 Filed Mar 6, 2019 00:48 UTC
Llorca JesusEVP & CFO
Tax withholdingCommon Stock 2,789 $14.01 $39,073.89
Disclosure

SEC source: 0001209191-19-017108 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,836

Read SEC document
March 04, 2019 Filed Mar 15, 2019 22:07 UTC Amendment
Llorca JesusEVP & CFO
Tax withholdingCommon Stock 3,376 $14.01 $47,297.76
Disclosure

SEC source: 0001209191-19-019798 · doc4a.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,249

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:51 UTC
Gellert John MDirector · President and CEO
OtherCommon Stock 841 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-017112 · doc4.xml · nonDerivative · entry 1

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · JMG Assets LLC

Disclosed balance after: 45,871

F1 · kind: Distribution from Pigeon Forge Investors ("PFI"), of which the Reporting Person is a partner. Such distribution represents the Reporting Person's pecuniary interest in a distribution from de Got Capital Partners, LP ("dCP") to PFI, which is a limited partner of dCP, as part of the winding up of the business of dCP.

F2 · ownership.nature: The shares reported here are indirectly owned by the Reporting Person through JMG Assets LLC. The Reporting Person is the Manager of JMG Assets LLC.

Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:21 UTC
Weller AnthonySr VP and Managing Dir.
GrantStock Options (right to buy) · Derivative 1,875 $0.00 Strike: $11.76 $0.00
Disclosure

SEC source: 0001437749-19-000081 · rdgdoc.xml · derivative · entry 1

Weller Anthony · CIK 0001705744 · Sr VP and Managing Dir.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:21 UTC
Gellert John MDirector · President and CEO
GrantStock Options (right to buy) · Derivative 10,000 $0.00 Strike: $11.76 $0.00
Disclosure

SEC source: 0001437749-19-000083 · rdgdoc.xml · derivative · entry 1

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:21 UTC
Llorca JesusExecutive Vice President
GrantStock Options (right to buy) · Derivative 6,250 $0.00 Strike: $11.76 $0.00
Disclosure

SEC source: 0001437749-19-000082 · rdgdoc.xml · derivative · entry 1

Llorca Jesus · CIK 0001705427 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:20 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantStock Options (right to buy) · Derivative 2,500 $0.00 Strike: $11.76 $0.00
Disclosure

SEC source: 0001437749-19-000080 · rdgdoc.xml · derivative · entry 1

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:20 UTC
Clemons RobertExecutive VP and COO
GrantStock Options (right to buy) · Derivative 6,250 $0.00 Strike: $11.76 $0.00
Disclosure

SEC source: 0001437749-19-000079 · rdgdoc.xml · derivative · entry 1

Clemons Robert · CIK 0001705909 · Executive VP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document
December 21, 2018 Filed Dec 21, 2018 22:49 UTC
Gellert John MDirector · President and CEO
PurchaseCommon Stock 23,000 $12.10 $278,329.90
Disclosure

SEC source: 0001437749-18-022545 · rdgdoc.xml · nonDerivative · entry 1

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · JMG Assets LLC

Disclosed balance after: 45,030

F1 · price: The price reported in Column 4 is a weighted average price. The Common shares were purchased in separate transactions on the same day at prices ranging from $11.645 to $12.28 per share. The Reporting Person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares reported here are indirectly owned by the Reporting Person through JMG Assets, LLC. The Reporting Person is the Manager of JMG Assets, LLC.

Read SEC document
November 21, 2018 Filed Nov 26, 2018 17:25 UTC SaleCommon Stock 20,000 $19.25 $385,026.00
Disclosure

SEC source: 0001690334-18-000090 · wf-form4_154327110985572.xml · nonDerivative · entry 1

FABRIKANT CHARLES · CIK 0000942692 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 462,659

F1 · price: The price reported in Column 4 is a weighted average price. The Common Shares were sold in separate transactions on the same day at prices ranging from $19.10 to $19.455 per share. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 21, 2018 Filed Feb 14, 2019 16:15 UTC GiftCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-010126 · doc5.xml · nonDerivative · entry 4

FABRIKANT CHARLES · CIK 0000942692 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · VSS Holding Corp.

Disclosed balance after: 65,459

F1 · ownership.nature: Reporting Person is the President and sole stockholder.

Read SEC document
November 15, 2018 Filed Nov 15, 2018 22:01 UTC
Weller AnthonySr VP and Managing Dir.
PurchaseCommon Stock 500 $18.00 $9,000.00
Disclosure

SEC source: 0001690334-18-000088 · wf-form4_154231924549148.xml · nonDerivative · entry 1

Weller Anthony · CIK 0001705744 · Sr VP and Managing Dir.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,910

Read SEC document
October 01, 2018 Filed Oct 2, 2018 21:04 UTC
Llorca JesusExecutive Vice President
GrantStock Options (right to buy) · Derivative 6,250 $0.00 Strike: $22.38 $0.00
Disclosure

SEC source: 0001690334-18-000086 · wf-form4_153851427715191.xml · derivative · entry 1

Llorca Jesus · CIK 0001705427 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document
October 01, 2018 Filed Oct 2, 2018 21:04 UTC
Gellert John MDirector · President and CEO
GrantStock Options (right to buy) · Derivative 10,000 $0.00 Strike: $22.38 $0.00
Disclosure

SEC source: 0001690334-18-000085 · wf-form4_153851424714822.xml · derivative · entry 1

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document
October 01, 2018 Filed Oct 2, 2018 21:03 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantStock Options (right to buy) · Derivative 2,500 $0.00 Strike: $22.38 $0.00
Disclosure

SEC source: 0001690334-18-000084 · wf-form4_153851421856063.xml · derivative · entry 1

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document
October 01, 2018 Filed Oct 2, 2018 21:03 UTC
Clemons RobertExecutive VP and COO
GrantStock Options (right to buy) · Derivative 6,250 $0.00 Strike: $22.38 $0.00
Disclosure

SEC source: 0001690334-18-000083 · wf-form4_153851419369113.xml · derivative · entry 1

Clemons Robert · CIK 0001705909 · Executive VP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2028-04-24

F1 · derivative.exercise_date: The stock option award reported on this Form 4 is exercisable in four equal annual installments beginning on March 4, 2019 and ending on March 4, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.